Reach a highly targeted audience of over 22,000 verified LinkedIn professionals by sponsoring The Biotech Edge, a leading weekly newsletter at the frontier of biotech and advanced technology.

The newsletter attracts senior decision-makers, investors, scientists, founders, and technologists who closely follow topics such as:

• artificial intelligence (AI) in drug discovery,

• pharma digitalization and software platforms,

• clinical trial technology,

• tools and methods (e.g., next-generation sequencing (NGS), Cryo-EM, AI-augmented mass spectrometry and NMR, etc),

• biobanks,

• brain-computer interfaces (BCIs),

• organ-on-chip systems,

• 3D bioprinting and biomaterials,

• quantum computing for biomedical applications, etc.

As the editor of the newsletter and a recognized voice in the tech+bio space, I ensure that sponsored messages are aligned with the interests and expectations of this expert audience.

Sponsored issues remain permanently accessible on LinkedIn, continuing to generate visibility and engagement long after publication.

If you're building innovative solutions in the biomedical field, this is your opportunity to showcase them to an influential, niche audience that cares deeply about the future of biotech.

Contact me at editor@andriibuvailo.com or via Contact Form to learn more.